Agilent Technologies SureSelect Human All Exon V8

Agilent Technologies has launched its SureSelect Human All Exon V8 tool. The firm said the product is a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GenCode. The tool also covers the TERT promoter and hard-to-capture exons. The firm said the new design spans a 35.1 Mb target region of the human genome and delivers excellent enrichment performance for more uniform coverage, as well as efficient and cost-effective exome sequencing. 

Agilent offers the new design in three versions: routine exome sequencing (Exome v8); clinical research sequencing (v8 Clinical Plus); and translational research (v8 UTR Plus).